ARIAD Pharma (ARIA) Tops Q2 EPS Views
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.53 -0.97%
Financial Fact:
Research and development: 43.63M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Research and development: 43.63M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
ARIAD Pharma (NASDAQ: ARIA) reported Q2 EPS of $0.59, $0.70 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $65.3 million versus the consensus estimate of $60.64 million.
For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
- XP Inc. (XP) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
